Patients & Visitors

Health Care Professionals

Residents & Fellows

Donors & Volunteers

Careers

Employees

 

Patient Resources

 

 

Bone Marrow Transplant Performance Results

SAFE AND EFFECTIVE CARE

Monitoring our care helps us evaluate and improve the way we deliver care. We emphasize areas where experts agree on the best treatment for a certain condition. (For more detail, click on each underlined measure below. A dash " - " means that there is no available comparison.)

 DHMC 2002-2009 Top 10% Average
HOSPITAL STAY

Back to Top
Average length of hospital stay: The average total number of days that patients stay at the hospital for their autologous transplant. 24
Days 		- 23
Days
Time for the transplant to take hold: The average number of days until engraftment (the time until the transplant takes hold) for autologous transplants. 14
Days 		- -
SURVIVAL - Multiple Myeloma

Back to Top
Multiple myeloma - 100 day survival: Percent of multiple myeloma patients living 100 or more days following their autologous transplant procedure. 100% - 97%
Multiple myeloma - 1 year survival: Percent of multiple myeloma patients living one or more years following their autologous transplant procedure. 91% - 89%
Multiple myeloma - 3 year survival: Percent of multiple myeloma patients living three or more years following their autologous transplant procedure. 71% - 67%
Multiple myeloma - 5 year survival: Percent of multiple myeloma patients living five or more years following their autologous transplant procedure. 58% - 49%
SURVIVAL - Leukemia

Back to Top
Leukemia - 100 day survival: Percent of acute myelogenous leukemia (AML) patients living 100 or more days following their autologous transplant procedure. 86% - 94%
Leukemia - 1 year survival: Percent of acute myelogenous leukemia (AML) patients living one or more years following their autologous transplant procedure. 56% - 68%
Leukemia - 3 year survival: Percent of acute myelogenous leukemia (AML) patients living three or more years following their autologous transplant procedure. 32% - 46%
Leukemia - 5 year survival: Percent of acute myelogenous leukemia (AML) patients living five or more years following their autologous transplant procedure. 41% - 39%
SURVIVAL - Non-Hodgkin's Lymphoma

Back to Top
Non-Hodgkin's Lymphoma - 100 day survival: Percent of Non-Hodgkin's lymphoma patients living 100 or more days following their autologous transplant procedure. 93% - 93%
Non-Hodgkin's Lymphoma - 1 year survival: Percent of Non-Hodgkin's lymphoma patients living one or more years following their autologous transplant procedure. 80% - 77%
Non-Hodgkin's Lymphoma - 3 year survival: Percent of Non-Hodgkin's lymphoma patients living three or more years following their autologous transplant procedure. 62% - 61%
Non-Hodgkin's Lymphoma - 5 year survival: Percent of Non-Hodgkin's lymphoma patients living five or more years following their autologous transplant procedure. 53% - 53%
WHAT OUR PATIENTS SAY ABOUT US

We ask our patients to rate our care as one way to evaluate and improve our services. (For more detail, click on each underlined measure below. A dash " - " means that there is no available comparison.)

 DHMC 2007-2009 Top 10% Average
HOSPITAL STAY

Back to Top
Overall care: BMT patients rated the overall care they received during their hospital stay using a scale of Very Good (100) to Very Poor (0). 94
 - 89
Nursing care: BMT patients rated the nurses who cared for them during their hospital stay using a scale of Very Good (100) to Very Poor (0). 94
 - 88
Visitor and family services: BMT patients rated services for visitors and family at the hospital using a scale of Very Good (100) to Very Poor (0). 89
 - 86
Emotional support: BMT patients rated how well their emotional and spiritual needs were met during their hospital stay using a scale of Very Good (100) to Very Poor (0). 88
 - 84
Pain management: BMT patients rated how well their pain was controlled during their hospital stay using a scale of Very Good (100) to Very Poor (0). 90
 - 86
APPOINTMENT WITH DOCTOR

Back to Top
Likely to return for care: BMT patients rated how likely they are to return to Dartmouth Hitchcock for care using a scale of Very Good (100) to Very Poor (0). 91
 - -
Likely to recommend: BMT patients rated how likely they are to recommend Dartmouth Hitchcock using a scale of Very Good (100) to Very Poor (0). 93
 - -
Doctors' clinical skills: BMT patients rated the clinical skills of their doctor using a scale of Excellent (100) to Poor (0). 94
 - -
Doctors' thoroughness: BMT patients rated the thoroughness of their doctor using a scale of Excellent (100) to Poor (0). 93
 - -
Involved in decisions: BMT patients rated how well they were involved in their medical decisions using a scale of Excellent (100) to Poor (0). 89
 - -
Nurses' caring/concern: BMT patients rated the caring and concern shown by nursing staff during a visit to their doctor using a scale of Excellent (100) to Poor (0). 88
 - -
Staff sensitivity: BMT patients rated the sensitivity of all staff to their personal needs during a visit to their doctor using a scale of Excellent (100) to Poor (0). 89
 - -
Conversation about paying for care: BMT patients rated the conversation about what they will need to pay for care using a scale of Excellent (100) to Poor (0). 82
 - -
Helped you find a way to pay: BMT patients rated the helpfulness of finding a way to pay using a scale of Excellent (100) to Poor (0). 75
 - -
Where to go for more information

We are interested in your feedback and questions. Please send email to: QualityReports@hitchcock.org to let us know if this is helpful, or if you need something you can't find here.